BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

258 related articles for article (PubMed ID: 16912955)

  • 1. Delivery of antiretroviral therapy in sub-saharan Africa.
    Weller I
    Clin Infect Dis; 2006 Sep; 43(6):777-8. PubMed ID: 16912955
    [No Abstract]   [Full Text] [Related]  

  • 2. Reconsidering the impact of conflict on HIV infection among women in the era of antiretroviral treatment scale-up in sub-Saharan Africa: a gender lens.
    Shannon K; Kaida A; Rachlis B; Lloyd-Smith E; Gray G; Strathdee SA
    AIDS; 2008 Sep; 22(14):1705-7. PubMed ID: 18753938
    [No Abstract]   [Full Text] [Related]  

  • 3. Interventions to reduce mortality in sub-Saharan Africa among HIV-infected adults not yet on antiretroviral therapy.
    Peterson K; van Griensven J; Huis in 't Veld D; Colebunders R
    Expert Rev Anti Infect Ther; 2012 Jan; 10(1):43-50. PubMed ID: 22149613
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Lack of appropriate treatment for people with comorbid HIV/AIDS and epilepsy in sub-Saharan Africa.
    Birbeck G; Chomba E; Ddumba E; Kauye F; Mielke J
    Epilepsia; 2007 Jul; 48(7):1424-5. PubMed ID: 17635568
    [No Abstract]   [Full Text] [Related]  

  • 5. Different delivery models for antiretroviral therapy in sub-Saharan Africa in the context of 'universal access'.
    Harries AD; Makombe SD; Schouten EJ; Ben-Smith A; Jahn A
    Trans R Soc Trop Med Hyg; 2008 Apr; 102(4):310-1. PubMed ID: 18316103
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The real challenges for scaling up ART in sub-Saharan Africa.
    Van Damme W; Kober K; Laga M
    AIDS; 2006 Mar; 20(5):653-6. PubMed ID: 16514294
    [No Abstract]   [Full Text] [Related]  

  • 7. Antiretroviral therapy for HIV prevention: many concerns and challenges, but are there ways forward in sub-Saharan Africa?
    Zachariah R; Harries AD; Philips M; Arnould L; Sabapathy K; O'Brien DP; Ferreyra C; Balkan S
    Trans R Soc Trop Med Hyg; 2010 Jun; 104(6):387-91. PubMed ID: 20116814
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [The HIV pandemic in the year 2007, an overview].
    Bartelsman M; Veeken H
    Ned Tijdschr Geneeskd; 2007 Dec; 151(48):2655-60. PubMed ID: 18179081
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Changing roles and responses of health care workers in HIV treatment and care.
    Rajaraman D; Palmer N
    Trop Med Int Health; 2008 Nov; 13(11):1357-63. PubMed ID: 19055620
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Severe opportunistic infections in HIV-positive adults in sub-Saharan Africa].
    Anglaret X
    Med Trop (Mars); 2006 Aug; 66(4):343-5. PubMed ID: 16999042
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Expanding access to antiretroviral therapy in sub-saharan Africa: avoiding the pitfalls and dangers, capitalizing on the opportunities.
    McCoy D; Chopra M; Loewenson R; Aitken JM; Ngulube T; Muula A; Ray S; Kureyi T; Ijumba P; Rowson M
    Am J Public Health; 2005 Jan; 95(1):18-22. PubMed ID: 15623853
    [TBL] [Abstract][Full Text] [Related]  

  • 12. HIV/AIDS in 2004: the epidemiologist's point of view.
    Girardi E; Lauria FN; Ippolito G
    Cell Death Differ; 2005 Aug; 12 Suppl 1():837-44. PubMed ID: 15776000
    [No Abstract]   [Full Text] [Related]  

  • 13. Finding patients eligible for antiretroviral therapy using TB services as entry point for HIV treatment.
    Bwire R; Nagelkerke NJ; Borgdorff MW
    Trop Med Int Health; 2006 Oct; 11(10):1567-75. PubMed ID: 17002731
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Antiretroviral therapy in sub-Saharan Africa: myth or reality?
    Kebba A
    J Antimicrob Chemother; 2003 Nov; 52(5):747-9. PubMed ID: 14563895
    [No Abstract]   [Full Text] [Related]  

  • 15. "Nothing new": responses to the introduction of antiretroviral drugs in South Africa.
    Chopra M; Kendall C; Hill Z; Schaay N; Nkonki LL; Doherty TM
    AIDS; 2006 Oct; 20(15):1975-7. PubMed ID: 16988520
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Directly observed therapy for HIV/tuberculosis co-infection.
    Lurie MN; Carter EJ; Cohen J; Flanigan TP
    Lancet Infect Dis; 2004 Mar; 4(3):137-8. PubMed ID: 14998498
    [No Abstract]   [Full Text] [Related]  

  • 17. The status of HIV-1 resistance to antiretroviral drugs in sub-Saharan Africa.
    Hamers RL; Derdelinckx I; van Vugt M; Stevens W; Rinke de Wit TF; Schuurman R;
    Antivir Ther; 2008; 13(5):625-39. PubMed ID: 18771046
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Provision of antiretroviral therapy to children within the public sector of South Africa.
    Bock P; Boulle A; White C; Osler M; Eley B
    Trans R Soc Trop Med Hyg; 2008 Sep; 102(9):905-11. PubMed ID: 18656217
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A new global commitment to disease control in Africa.
    Sachs JD
    Nat Med; 2001 May; 7(5):521-3. PubMed ID: 11329042
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Antiretroviral therapy: what about food?
    Agnarson AM; Ericson J; Ekström AM; Thorson A
    AIDS; 2007 May; 21(9):1225-6. PubMed ID: 17502741
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 13.